I spent eight years buying research compounds for an academic lab. Half of what arrived was either underdosed, contaminated, or shipped with documentation that didn’t match the label. The good suppliers existed — they just didn’t sell to anyone outside of an institution.
hábit is the supplier I wished existed. Pharmaceutical-grade synthesis, third-party verification, and the kind of design and documentation that signals seriousness without performing it. We don’t make therapeutic claims. We don’t sell to anyone who isn’t a qualified researcher. And we don’t cut corners on the parts of the process nobody sees.
The brand is small on purpose. We will not become a marketplace. We will not white-label. We will not chase compounds that haven’t earned their place in the literature. What we ship, we stand behind — to the milligram, to the lot, to the COA.
— [Founder name], Founder & Chief Scientific Officer
Every lot is tested twice — once by us, once by a third party. The second test is the one that matters. We do not ship anything we have not proven.
We publish the COA. We publish the synthesis route. We publish the supplier audit on request. If you ask a question, you get an answer — usually within the day, always within the week.
We do not make therapeutic claims. We do not chase trends. We do not sell to anyone who is not a qualified researcher. The catalog stays small. The standards stay high.